📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Large-scale (Phase III) evaluation of broflanilide 50WP (VECTRONâ„¢ T500) for indoor residual spraying for malaria vector control in Northeast Tanzania: study protocol for a two-arm, non-inferiority, cluster-randomised community trial. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12879-022-07138-3

PubMed Identifier: 35189830

Publication URI: http://europepmc.org/abstract/MED/35189830

Type: Journal Article/Review

Volume: 22

Parent Publication: BMC infectious diseases

Issue: 1

ISSN: 1471-2334